Exenatide and Postprandial Endothelial Dysfunction: Effects and Mechanisms.

Trial Profile

Exenatide and Postprandial Endothelial Dysfunction: Effects and Mechanisms.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Exenatide (Primary) ; Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Jun 2015 Results (substudy 1, n=36) presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 19 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 03 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top